Concepedia

Author

Lillian Reich

Memorial Sloan Kettering Cancer Center

Also Known As

I Elezović, L Reich, L. Reich, Lillian M Reich, Lillian Reich

20

Publications

931

Citations

11

H-Index

48

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterCornell University
LR

About

Lillian Reich is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

512

2

Health Sciences

3

3

259

3

Cell Biology

2

2

28

4

Allergy

1

1

210

5

Cellular Therapies

1

1

12

Lillian Reich

×

12

Publications

905

Citations

11

H-Index

YearCitations

Transfusion-Associated Acute Chagas Disease Acquired in the United States

Irene Grant, Jonathan Gold, Murray Wittner,

Annals of Internal Medicine

1989

229

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes

Henry Furneaux, Lillian Reich, Jerome B. Posner

Neurology

1990

210

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

G. Varuni Kondagunta, Jennifer Bacik, Joel Sheinfeld,

Journal of Clinical Oncology

2006

136

Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).

Sanford Kempin, B. J. Lee, Howard T. Thaler,

PubMed

1982

89

Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer

F.L. Shapiro, TJ Yao, George E. Raptis,

Blood

1994

71

Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.

Ellin Berman, Z Arlin, Jeffrey J. Gaynor,

PubMed

1989

51

Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.

Carol Aghajanian, D. Fennelly, F.L. Shapiro,

Journal of Clinical Oncology

1998

46

Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.

D. Fennelly, Carolyn Wasserheit, Juliane Schneider,

PubMed

1994

18

Immune-mediated thrombocytopenia secondary to suramin

Andrew D. Seidman, Michael Schwartz, Lillian Reich,

Cancer

1993

16

Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.

Linda T. Vahdat, George Raptis, D. Fennelly,

PubMed

1995

16

Page 1